PHENAMAZOLINE
UNII 09L091X49E

Substance Identification & Data

This profile provides standardized clinical and technical data for Phenamazoline, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 09L091X49E.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 501-62-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

09L091X49E

CAS Registry Number

501-62-2

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

PHENAMAZOLINE

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C10H13N3

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

FPZTYKLEJPXTKD-UHFFFAOYSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C66365

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

3084422

Unique identification number in the NCBI database of chemical substances.

INN ID

643

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

N1CCN=C1CNc2ccccc2

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Phenamazoline. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.